S Trimer Derived from SARS-CoV-2 B.1.351 and B.1.618 Induced Effective Immune Response against Multiple SARS-CoV-2 Variants
The spread of SARS-CoV-2 and its variants leads to a heavy burden on healthcare and the global economy, highlighting the need for developing vaccines that induce broad immunity against coronavirus. Here, we explored the immunogenicity of monovalent or bivalent spike (S) trimer subunit vaccines deriv...
Auteurs principaux: | Hongye Wang, Zengshuai Wang, Liang Ma, Xiaoyong Zhu, Bingxiang Li, Yuhang Huang, Jingwen Li, Ming Sun, Li Shi, Yufeng Yao |
---|---|
Format: | Article |
Langue: | English |
Publié: |
MDPI AG
2023-01-01
|
Collection: | Vaccines |
Sujets: | |
Accès en ligne: | https://www.mdpi.com/2076-393X/11/1/193 |
Documents similaires
-
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
par: David R. Martinez, et autres
Publié: (2021-07-01) -
The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice
par: Cheng Zhang, et autres
Publié: (2022-04-01) -
The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
par: Yeong Jun Kim, et autres
Publié: (2021-04-01) -
A novel nanobody broadly neutralizes SARS‐CoV‐2 via induction of spike trimer dimers conformation
par: Yang Yang, et autres
Publié: (2024-06-01) -
A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2
par: Ankit Gupta, et autres
Publié: (2021-12-01)